Original research: A patented strain of Bacillus coagulans increased immune response to viral challenge

Postgraduate Medicine

Volumn 121, Issue 2, 2009, Pages 114-118

  Baron, Mira ^a  

^a Rapid Medical Research Inc ^*  (United States)

Author keywords

Bacillus coagulans; GanedenBC30; Immune response; Lactic acid producing bacteria; Probiotics; Respiratory tract infection

Indexed keywords

CYTOKINE; GBI 30 6086; PROBIOTIC AGENT; SUSTENEX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INTERFERON;

ABSENCE OF SIDE EFFECTS; ADENOVIRUS; ADULT; ARTICLE; BACILLUS COAGULANS; BACTERIAL STRAIN; CYTOKINE PRODUCTION; DRUG CAPSULE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLUENZA VIRUS A; INFLUENZA VIRUS A H3N2; MALE; NORMAL HUMAN; PATIENT COMPLIANCE; T LYMPHOCYTE; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS INFECTION; VIRUS STRAIN; ADENOVIRUS INFECTION; BACILLUS; BLOOD; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; INFLUENZA; MIDDLE AGED; RESPIRATORY TRACT INFECTION; VIROLOGY;

ADENOVIRUS INFECTIONS, HUMAN; ADULT; BACILLUS; FEMALE; HUMANS; IMMUNITY, CELLULAR; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; INTERFERONS; MALE; MIDDLE AGED; PROBIOTICS; RESPIRATORY TRACT INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66849141116     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2009.03.1971     Document Type: Article

References (20)

1. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163(4):487-494. (Pubitemid 36244917)
2. Centers for Disease Control and Prevention. Influenza: the disease. http:// www.cdc.gov/flu/about/disease/index.htm. Accessed July 28, 2008.
3. National Institute of Allergy and Infectious Diseases of the National Institutes of Health. Common cold. http://www3.niaid. nih.gov/healthscience/ healthtopics/colds/overview.htm. Accessed July 30, 2008.
4. Fendrick AM. Viral respiratory infections due to rhinoviruses: current knowledge, new developments. Am J Ther. 2003;10(3):193-202.
5. Cross ML, Ganner A, Teilab D, Fray LM. Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immunol Med Microbiol. 2004;42(2):173-190. (Pubitemid 39208544)
6. De Vecchi E, Drago L. Lactobacillus sporogenes or bacillus coagulans: misidentification or mislabeling? Int. J Probiotics and Prebiotics. 2006;1:3-10.
7. Yasui H, Kiyoshima J, Hori T. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol. 2004;11(4): 675-679. (Pubitemid 38943988)
8. Hatakka K, Savilahti E, Pönkä A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ. 2001;322(7298):1-5. (Pubitemid 32521266)
9. Breed RS, Murray EGD, Smith NR, et al. Bergey's Manual of Determinative Bacteriology. 7th ed. Baltimore, MD: The Williams and Wilkins Co; 1957.
10. Ara K, Meguro S, Hase T, et al. Effect of spore-bearing lactic acid- forming bacteria (Bacillus coagulans SANK 70258) administration on the intestinal environment, defection frequency, fecal characteristics anil dermal characteristics in humans and rats. Microb Ecol Health Dis. 2002;14:4-13. (Pubitemid 34429185)
11. Perdigón G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol. 2001;2(1):27-42. (Pubitemid 32401085)
12. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005;115(1):178-181. (Pubitemid 43046298)
13. Ishihashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr. 2001;73(2 suppl):465S-470S.
14. Winkler P, de Vrese M, Laue Ch, Schrezenmeir J. Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. Int J Clin Pharmacol Ther. 2005;43(7):318-326. (Pubitemid 40974738)
15. Turchel P, Laurenzano M, Auboiron S, Antoine J M. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging. 2003;7(2):75-77. (Pubitemid 36506204)
16. de Vrese M, Winkler P, Rautenberg P, et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine. 2006;24(44-46):6670-6674. (Pubitemid 46107165)
17. Boirivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol. 2007;23(6):679-692. (Pubitemid 47508800)
18. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000;130(2 suppl):396S-402S. (Pubitemid 30073758)
19. Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr. 2001;73(2suppl): 393S-398S. (Pubitemid 32113261)
20. Marco ML, Pavan S, Kleerebezem M. Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol. 2006;17(2):204-210.